MAGIC-I, which is Ireland’s first clinical study of genomics approaches in cancer care, will seek to establish the processes ...

Terumo Blood and Cell Technologies (Terumo BCT) has announced the appointment of Patrick Daly as its Chief Business Officer.

Researchers from University College London (UCL) are aiming to develop potential treatments for congenital muscular dystrophy ...

Novavax has shared positive preliminary results from a real-world study of its JN.1-adapted COVID-19 vaccine. The SHIELD-Utah ...

Clinical-stage biopharma Kymera Therapeutics has announced the appointment Noah Goodman as its new Chief Business Officer.

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley, Vice President and General ...

The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet therapy could offer ...

The European Commission has granted marketing authorisation for Leqembi (lecanemab), making it the first therapy in the EU to slow the progression of early Alzheimer’s disease.

Birmingham researchers have received £230k from Cancer Research Horizons to develop a prototype test for monitoring people ...

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...